Cohort 1 (2019 - 2023)
Cohort 1 (2019 - 2023)
Code | Title | Supervisor |
---|---|---|
19-01 | Evaluation of nitrated-chemokines to monitor ischaemia reperfusion injury in organ transplantation | Simi Ali, Newcastle |
19-02 | Chimeric small molecule tools to investigate glucose metabolism | Celine Cano, Newcastle |
19-03 | Protein aptamers to enable structure-based drug discovery – making the undruggable druggable | Martin Noble, Newcastle |
19-04 | Development of MRI scan methods to image inhaled fluorocarbon gases as biomarkers of lung structure and function | Pete Thelwall, Newcastle |
19-05 | Development of cell-based drug discovery assays using high-throughput MALDI TOF mass spectrometry | Matthias Trost, Newcastle |
19-06 | Expanding the scope of metal catalysed DNA-encoded library synthesis | Mike Waring, Newcastle |
19-07 | Predicting enzyme metalation to identify new therapeutic targets in infectious diseases | Peter Chivers, Durham |
19-08 | The Development of new chemical tools to study chemokines properties and biological functions | Steven Cobb, Durham |
19-09 | Deconvoluting the mode of action of a suite of novel antileishmanials | Paul Denny, Durham |
19-10 | Nitron derivatives to Blatter radicals: novel anti-cancer prodrugs and mechanistic probes | AnnMarie O'Donoghue, Durham |
19-11 | Biological tools from phage-resistance systems | Tim Blower, Durham |